Mass balance, metabolism, and pharmacokinetics of [14C]amdizalisib, a clinical-stage novel oral selective PI3Kδ inhibitor for the treatment of non-hodgkin’s lymphoma, in healthy Ch... by Chun-Yang Zhao, Chun-Yang Zhao, Li-Jun Zhang, Li-Jun Zhang, Chan Sun, Chan Sun, Cheng-Yin Yu, Cheng-Yin Yu, Cheng-Yin Yu, Jian Wang, Yang Sai, Wei-Guo Su, Qian Chen, Qian Chen, Wei Wang, Wei Wang, Jing-Ying Jia, Jing-Ying Jia, Gang-Yi Liu, Gang-Yi Liu, Yan-Mei Liu, Yan-Mei Liu

Get full text